VYNE Therapeutics Inc (VYNE)
2.55
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
2.63
+0.08
(+3.14%)
After-Hours: 20:00
VYNE Therapeutics Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 19.60M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
19.60M
Minimum
Dec 2020
19.60M
Maximum
Dec 2020
19.60M
Average
19.60M
Median
Dec 2020
Gross Profit (TTM) Benchmarks
| Viking Therapeutics Inc | -- |
| AN2 Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 7.753M |
| Palatin Technologies Inc | 5.700M |
| iBio Inc | -- |